Although androgen deprivation is an effective treatment, 20–30% of the cancers become resistant [23], paradoxically allowing the disease to progress through alternative signaling pathways, including AR mutations, splice variants, and increased production of growth factors [24]. The gene discussed is AR; the disease is cancer.